Dr. David C. Madoff Appointed Interventional Radiology Chief at NewYork-Presbyterian/Weill Cornell

Dr. Madoff Is a Leading Authority in Image-Guided Minimally Invasive Cancer Treatments

Apr 29, 2011


An internationally recognized expert in the emerging field of interventional oncology, Dr. David C. Madoff has been named chief of interventional radiology at NewYork-Presbyterian Hospital/Weill Cornell Medical Center. He was also appointed as professor of radiology at Weill Cornell Medical College.

Dr. Madoff is known as an innovator and leading academic practitioner of interventional radiology, a field that utilizes minimally invasive image-guided techniques to diagnose and treat a wide range of disorders. He is expert in treating a variety of thoracic, gastrointestinal, hepatobiliary and genitourinary diseases, and he has extensive experience with advanced percutaneous biopsy techniques.

His particular area of clinical and research expertise is interventional oncology, including catheter-based and ablative treatments for various solid organ malignancies, especially primary and metastatic liver cancer therapy. These treatments can serve either as a bridge-to-transplant for patients who are candidates but not yet able to receive a liver transplant, or as a palliative method to prolong survival while maintaining a high quality of life. Dr. Madoff participates in numerous clinical trials for liver cancer treatment, which include novel transarterial strategies for drug and radiation delivery. In the upcoming months, he plans to bring new and exciting clinical trials related to cancer treatment to NewYork-Presbyterian/Weill Cornell.

Dr. Madoff is also a world authority in preoperative portal vein embolization, a technique used to improve the safety of major liver surgery by stimulating the growth of healthy liver tissue; without this procedure, many patients would be ineligible for surgery to remove their liver cancer. He helped develop the technique, has published extensively on the subject and is the editor of a textbook on the topic entitled "Venous Embolization of the Liver: Radiological and Surgical Practice" that will be published later this year.

"I am very pleased to welcome Dr. Madoff, an outstanding clinician, scientist and educator with unique expertise in a wide range of complex cancers, particularly liver cancer," says Dr. Robert J. Min, radiologist-in-chief at NewYork-Presbyterian Hospital/Weill Cornell Medical Center and chairman of the Department of Radiology at Weill Cornell Medical College.

Going forward, Dr. Madoff plans research into the use of nanotechnology, stem cells and other novel approaches to aid in liver regeneration and to develop new minimally invasive techniques to treat oncologic patients. He also has great interest in improving methods for targeting tumors during treatment and assessing response. The Interventional Radiology team he leads is currently very active in treating patients with uterine fibroids, venous disease and renal disease, and Dr. Madoff plans to add new treatment areas.

Dr. Madoff earned his B.A. from Emory University and his M.D. from the University of Pittsburgh School of Medicine. He completed both his internship in internal medicine and his residency in diagnostic radiology at the State University of New York at Stony Brook. He then completed fellowship training in vascular and interventional radiology at The University of Texas M.D. Anderson Cancer Center in Houston. Dr. Madoff remained at M.D. Anderson, joining the Section of Vascular and Interventional Radiology in 2001 and rising to the level of associate professor of radiology with tenure.

Dr. Madoff is the author of more than 80 peer-reviewed articles, has written 15 book chapters and is the recipient of numerous honors and awards. He has been an invited speaker at numerous national and international society meetings and assemblies and has served as visiting professor at many institutions around the world. Dr. Madoff served as deputy editor-in-chief of the Journal of Vascular and Interventional Radiology (JVIR) from 2007 to 2010 and has been an active member of its editorial board since 2004. JVIR is the specialty's leading journal and the official journal of the Society of Interventional Radiology. In 2011, he will remain on the JVIR editorial board as an associate editor. Dr. Madoff also serves on the editorial boards of other publications, including Techniques in Vascular and Interventional Radiology and Seminars in Interventional Radiology.

Dr. Madoff is a member of numerous prestigious professional radiological organizations and has held many important positions within them. He currently serves as chairman of the Radiological Society of North America's Vascular/Interventional Radiology Educational Exhibits Committee for its annual meeting and served as chair of the 2009 American Roentgen Ray Society Scientific Program Interventional Radiology Subcommittee. Based on his important contributions to the field, Dr. Madoff was elected Fellow of the Society of Interventional Radiology in 2007.

"I look forward to working with clinicians in a wide variety of clinical specialties as we develop new treatments to help patients and continue to build one of the nation's leading interventional radiology programs," says Dr. Madoff.

For more information, patients may call 866-NYP-NEWS.

NewYork-Presbyterian Hospital/Weill Cornell Medical Center

NewYork-Presbyterian Hospital/Weill Cornell Medical Center, located in New York City, is one of the leading academic medical centers in the world, comprising the teaching hospital NewYork-Presbyterian and Weill Cornell Medical College, the medical school of Cornell University. NewYork-Presbyterian/Weill Cornell provides state-of-the-art inpatient, ambulatory and preventive care in all areas of medicine, and is committed to excellence in patient care, education, research and community service. Weill Cornell physician-scientists have been responsible for many medical advances — including the development of the Pap test for cervical cancer; the synthesis of penicillin; the first successful embryo-biopsy pregnancy and birth in the U.S.; the first clinical trial for gene therapy for Parkinson's disease; the first indication of bone marrow's critical role in tumor growth; and, most recently, the world's first successful use of deep brain stimulation to treat a minimally conscious brain-injured patient. NewYork-Presbyterian Hospital also comprises NewYork-Presbyterian Hospital/Columbia University Medical Center, NewYork-Presbyterian/Morgan Stanley Children's Hospital, NewYork-Presbyterian Hospital/Westchester Division and NewYork-Presbyterian/The Allen Hospital. NewYork-Presbyterian is the #1 hospital in the New York metropolitan area and is consistently ranked among the best academic medical institutions in the nation, according to U.S.News & World Report. Weill Cornell Medical College is the first U.S. medical college to offer a medical degree overseas and maintains a strong global presence in Austria, Brazil, Haiti, Tanzania, Turkey and Qatar. For more information, visit www.nyp.org and weill.cornell.edu.

Media Contact:

Public Affairs 212-821-0560